
Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' the immune system to recognize and destroy cancer. This novel approach stimulates a broad, virus-like immune response, making tumours more visible to attack and potentially preventing recurrence. The breakthrough offers a promising new direction for universal cancer prevention and treatment.